Merck KGaA (OTCMKTS:MKGAF - Get Free Report) saw a large increase in short interest in the month of October. As of October 31st, there was short interest totalling 284,600 shares, an increase of 19.7% from the October 15th total of 237,800 shares. Based on an average trading volume of 300 shares, the short-interest ratio is currently 948.7 days.
Merck KGaA Stock Performance
MKGAF stock traded down $2.00 during midday trading on Friday, reaching $150.00. 253 shares of the company were exchanged, compared to its average volume of 513. Merck KGaA has a one year low of $144.73 and a one year high of $200.56. The firm has a market capitalization of $19.39 billion, a price-to-earnings ratio of 22.03 and a beta of 0.96. The business has a 50-day moving average price of $170.99 and a two-hundred day moving average price of $175.92. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84.
Wall Street Analysts Forecast Growth
Separately, The Goldman Sachs Group upgraded Merck KGaA to a "strong-buy" rating in a report on Thursday, September 19th.
View Our Latest Stock Analysis on Merck KGaA
Merck KGaA Company Profile
(
Get Free Report)
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Merck KGaA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.
While Merck KGaA currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
